Podcast Episode

Why Women Spend the Last 5–6 Years of Life in Worse Health Than Men (And What to Do About It)

The LIVING Room Podcast | Inside The WNDR Lab
Sep 10, 20261 hr 29 minEN
Guest
JGJennifer Garrison

Who’s talking

2 speakers
Jennifer Garrison1 hr 9 min · 80%
Chris Wharton17 min · 20%

Transcript

368 turns · 1 hr 29 min
JG
Jennifer Garrison0:00

Ovaries are like a second brain. They talk to my heart, my bone, my muscle, my brain for sure, my liver. Almost every tissue in the female body is somehow connected to a variant signaling. The message is that ovaries are the architects of health in female bodies and also the pacemakers for aging. And so reproductive aging is really just intrinsic aging in reproductive organs that impairs fertility or fecundity, really just basically impairs your ability to reproduce aging ovaries drives aging and the rest of the body for women understanding what your normal is across time is probably the most important and most powerful thing that you can do women are desperate for answers how and why do ovaries age faster that's the key question for female health the idea that female bodies are noisy or that our cycles make things difficult to interpret that's just bullshit

CW
Chris Wharton1:04

Jen, welcome.

JG
Jennifer Garrison1:05

Thank you.

CW
Chris Wharton1:06

So I wanted to start today with just some very high-level statistics that I'd love you to tell me if

JG
Jennifer Garrison1:13

they're

CW
Chris Wharton1:14

correct or not, because this is kind of frightening. Only around 8% to 9% of NIH research funding is dedicated to women's health research.

JG
Jennifer Garrison1:24

Correct. Is

CW
Chris Wharton1:24

that correct?

JG
Jennifer Garrison1:24

That's correct,

CW
Chris Wharton1:25

yeah. 8% to 9%?

JG
Jennifer Garrison1:27

Somewhere, you know, it hovers. It changes every year, but it hovers around 10%.

CW
Chris Wharton1:32

only 5% of health R&D funding goes to women's

JG
Jennifer Garrison1:35

health. Yes, I might even say 4%. Yeah, that's correct.

CW
Chris Wharton1:40

And of that, it says here, 4% goes to women's cancers, just 1% towards all other female-specific conditions, menopause, endometriosis, PCOS, and infertility.

JG
Jennifer Garrison1:50

Well, it depends on which funding you're talking about. So if you're talking about private investment, for the last five years, you have to look at the historic data, for the last five years, That's approximately in the ballpark. Something like 4% of all the investment has gone to everything except female cancers, fertility, and maternal-fetal health. So that means that more than 95% of the investment has gone to those three areas. And everything else, quite literally everything else related to women's health is in that little tiny bucket.

CW
Chris Wharton2:31

I mean, help me and the audience understand why that might have happened.

JG
Jennifer Garrison2:35

I mean, OK, well, I think I think at this stage of the game, we're all familiar with the historical bias in research in terms of like sex bias towards male systems. like historic underfunding, right? So the underfunding really leads to this massive gap in data that we have. And I think that, you know, until recently, there was a real taboo around talking about female bodies, right? We didn't talk about pregnancy. We didn't talk about menstruation. Certainly from my mother and her mother talking to her would never have talked about, you know, Any of these things. And so that's changed and everything is changing in a positive direction. But, and I would say I, I like to, um, a dear friend, uh, CJ Jenkins likes to say, let's stop admiring the problem and actually just like fix it.

CW
Chris Wharton3:25

Deal with it. Yeah. We just, are we playing catch up now? Do you think?

JG
Jennifer Garrison3:29

I would say we're generations behind where we need to be. So we're missing an extraordinary amount of data on female bodies. I like to call it a puzzle that we haven't yet solved.

CW
Chris Wharton3:40

Does that have

Episode notes

Why do women spend the last 5–6 years of life in worse health than men — and what does it have to do with your ovaries? Only 8–9% of NIH research funding goes to women’s health research, and by some estimates as little as 4% of private R&D investment goes to anything outside female cancers, fertility, and maternal-fetal health combined. Meanwhile, cardiovascular disease risk can rise 2–4x almost overnight at menopause — a shift most women are never warned about.

In this episode, Chris is joined by Dr. Jennifer Garrison, PhD, a neuroscientist, Co-Founder and Executive Director of ProductiveHealth.org, who spearheads the science on ovarian health.

Most people — including doctors — have conflated ovarian aging with reproductive aging for decades. Garrison’s research shows they’re not the same thing: ovaries function as a signaling hub for the entire body, and when they decline, they take whole-body health down with them, independent of fertility.

In this episode, you’ll learn:

  • Why ovarian aging and reproductive aging are two different things — and why that distinction matters for your whole-body health
  • What the research funding gap actually looks like, in numbers
  • Why the 2002 hormone therapy scare was based on flawed study design — and what the data actually shows today
  • Why oral estradiol carries stroke risk but the transdermal patch doesn’t
  • What a landmark mouse

Showing a preview — retrieve the full transcript via the Exa API.

Powered by the Exa API